期刊文献+

血吸虫重组卡介苗-Sj26GST疫苗的构建及免疫原性的研究 被引量:6

Construction of recombinant BCG bearing Schistosoma japonicum 26Ku antigen gene and study on its immunogenicity on mice
原文传递
导出
摘要 目的 构建含日本血吸虫相对分子质量为 2 6 0 0 0的抗原 (Sj2 6GST)基因的重组卡介菌(rBCG)疫苗 ,观察其对BALB/c小鼠的免疫保护作用。方法 采用分子生物学技术 ,将Sj2 6GSTcDNA克隆到人结核杆菌热休克蛋白 (HSP) 70启动子下游 ,构成融合基因 ,再将此融合基因亚克隆到E .coli 分枝杆菌穿梭质粒pBCG 2 0 0 0中 ,构成重组质粒pBCG Sj2 6 ,然后转化卡介苗 (BCG) ,构成血吸虫重组BCG Sj2 6GST(rBCG Sj2 6GST)疫苗 ,经热诱导 ,在BCG中表达Sj2 6GST抗原。用rBCG Sj2 6GST疫苗皮下免疫BALB/c小鼠 ,以淋巴细胞刺激指数 (SI)反映细胞增殖能力 ,以NO释放量检测巨噬细胞吞噬活性 ,以ELISA试剂盒检测血清及脾淋巴细胞培养上清的白细胞介素 (IL) 2和干扰素 (IFN) γ的含量。结果 HSP70启动子与Sj2 6GSTcDNA融合基因已被克隆到pBCG 2 0 0 0穿梭表达质粒中 ,相对分子质量为 2 6 0 0 0处可见明显的表达蛋白带 ,其表达量占菌体总蛋白量的 15 %。rBCG Sj2 6GST疫苗以 10 6菌落形成单位 (CFU)经皮下免疫小鼠后 ,其脾SI为 2 .2 6± 0 .43,与对照组 (1.6 1± 0 .2 8) ,载体组(1.48± 0 .30 )和BCG组 (1.42± 0 .2 6 )比较 ,P <0 .0 5 ;巨噬细胞NO的含量为 35 7nmol/ml± 84nmol/ml,与对照组 (183nmol/ml± 33nmol/ml)和? Objective To construct recombinant BCG vaccine bearing Schistosoma japonicum 26Ku glutathione S transferase (Sj26GST) gene and determine its immunogenicity on BALB/c mice. Methods Using techniques of molecular biology, human mycobacterium tuberculosis HSP70 promoter and Sj26GST gene were linked to produce a fused gene. The fused gene was cloned into an E.coli Mycobacterium shuttle plasmid pBCG 2000 to construct an E. coli Mycobacterium expression shuttle plasmid pBCG Sj26 that could express Sj26GST gene. Then, the pBCG Sj26 was introduced by electroporation into mycobacterium bovis BCG to construct a recombinant BCG vaccine bearing Sj26GST gene ( rBCG Sj26GST). The expression of Sj26GST gene in BCG was induced by heating. The lymphocyte stimulating index (SI), macrophage activity and IL 2, IFN γ levels of the serum and culture supernatant of spleen lymphocytes were tested after immunization of BALB/c mice with rBCG Sj26GST vaccine. Results The fused gene of HSP70 promoter and Sj26GST cDNA was inserted into an E. coli Mycobacterium shuttle expression plasmid by analysing electrophoresis results on PCR products using plasmid pBCG Sj26 as a templet. The content of rSj26GST contained 15% of total bacterial protein of BCG. The SI of the experimental group was 2.26±0.43, which was significantly higher than those in the control group (1.61±0.28, P <0.05), vector group (1.48±0.30, P <0.05) and BCG group (1.42±0.26, P <0.05). The macrophage NO level of the experimental group was (357.42±84.11) nmol/ml which was significantly higher than those in the control group (183 nmol/ml±33 nmol/ml, P <0.01) and vector group (203 nmol/ml±56 nmol/ml, P <0.01). The serum IL 2 level of the experimental group was (267 pg/ml±130 pg/ml), which was significantly higher than those in the control group (45 pg/ml±15 pg/ml, P <0.01) and vector group (52 pg/ml±29 pg/ml, P <0.05). Compared with the control group, the serum IFN γ level increased by 20%, the IL 2 level of the culture supernatant of spleen lymphocytes increased by 44%. Conclusions The foreign gene encoding Sj26 GST can be expressed in BCG. rBCG Sj26GST vaccine may induce stronger immune response in BALB/c mice than in control, vector and BCG groups.
出处 《中华医学杂志》 CAS CSCD 北大核心 2000年第6期407-410,共4页 National Medical Journal of China
基金 总理基金!(94Y19) 国家自然科学基金!(39480 022)资助项目
关键词 日本血吸虫 疫苗 合成 基因表达 免疫原性 Schistosomides Vaccines synthetic Gene expression
  • 相关文献

参考文献4

二级参考文献2

共引文献17

同被引文献46

  • 1聂忠清,吴永刚,蒙建洲.分子伴侣的功能和应用[J].生命科学,2006,18(1):84-89. 被引量:21
  • 2金立杰,赵小琳,方艳秋,杨丽华,王志.乙型肝炎疫苗-卡介苗联合疫苗细胞免疫的研究[J].中国生物制品学杂志,2006,19(2):171-173. 被引量:5
  • 3程继忠,皇甫永穆.重组BCG疫苗的研究进展[J].微生物学杂志,1996,16(4):47-50. 被引量:10
  • 4赵小琳,刘延明,陈万革,金立杰.乙型肝炎卡介苗联合疫苗稳定性的研究[J].微生物学杂志,2007,27(2):41-44. 被引量:2
  • 5李雪翔 史久华 等.重组乙型肝炎疫苗肌肉和皮内接种的抗体应答率比较[J].国外医学(预防、诊断、治疗用生物制品分册),1993,16(6):263-263.
  • 6中国生物制品标准委员会.《中国生物制品规程》[S].北京:化学工业出版社,2000年版.86.
  • 7Yeh SH,Ward BJ,Partridge S, et al. Safety and immunogenicity of a pentavalent diphtheria, tetanus,pertussis,hepatitis B and polio combination vaccine in infants [J], Pediatr Infect Dis J ,2001,20(10): 973.
  • 8Keisari Y, Seger M, Lency J, et al. IL 1, TNF-α and IL-2 production by peritoneal and spleen cell from schistosom a mansonin infect mice and its potentation by perimmunization with schistosomal antigen and immunostimulants [J]. Immunobiol, 1993, 188: 446.
  • 9Egemen A, Aksit S, Kurugol Z, et al. Low dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children[J]. Vaccine, 1998,16(16) : 1511.
  • 10Edelman R;Palmer K;Russ K G.Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers:a candidate Lyme disease vaccine[J],1998(7-8).

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部